Results 31 to 40 of about 1,005,947 (300)
Using the Past to Maximize the Success Probability of Future Anti-Viral Vaccines. [PDF]
Vaccines (Basel), 2020 Rapid obtaining of safe, effective, anti-viral vaccines has recently risen to the top of the international agenda. To maximize the success probability of future anti-viral vaccines, the anti-viral vaccines successful in the past are summarized here by ...
Serwer P.
europepmc +2 more sources
Targeting Viral Surface Proteins through Structure-Based Design
, 2021 The emergence of novel viral infections of zoonotic origin and mutations of existing human pathogenic viruses represent a serious concern for public health.
Eva-Maria Strauch +2 more
core +1 more source
Virus-like Particle Vaccines and Platforms for Vaccine Development
, 2023 Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human papillomavirus, and hepatitis E virus—has been approved ...
Hong Liu +2 more
core +1 more source
Viruses, 2023 We previously reported a novel rhabdovirus produced from the Spodoptera frugiperda Sf9 cell line, designated as Sf-rhabdovirus X+ since it contained a unique accessory gene X.
Hailun Ma, Trent J. Bosma, Arifa S. Khan
doaj +1 more source
Summary of findings (viral vector vaccines).
, 2022 Summary of findings (viral vector vaccines).
Steven Kwasi Korang (11986314) +19 more
core +1 more source
Is It Time for Vaccination to “Go Viral”?
Pediatric Infectious Disease Journal, 2016 To promote and sustain excellent vaccination coverage, while preserving the key core values of ethics, truth, transparency and trust, the vaccine community should adopt modern digital communication strategies. This article summarizes our views-as experts in multidisciplinary field of vaccinology (consisting of an anthropologist, a public health policy ...
Philip, Roy K. +4 more
openaire +4 more sources
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
, 2020 Hepatitis B remains one of the major global health problems more than 40 years after the identification of human hepatitis B virus (HBV) as the causative agent.
Beena Jeevan-Raj +2 more
core +1 more source
Nature Communications, 2022 Here the authors show that a third SARS-CoV-2 vaccination significantly boosts neutralizing antibodies against Omicron subvariants and that hybrid immunity (infection and vaccination) results in broader neutralization activity and cross-reactive antibody
Lorenza Bellusci +6 more
doaj +1 more source
Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development [PDF]
BioDrugs, 2021 Vaccine-associated enhanced disease (VAED) is a serious barrier to attaining successful virus vaccines in human and veterinary medicine. VAED occurs as two different immunopathologies, antibody-dependent enhancement (ADE) and vaccine-associated hypersensitivity (VAH).
openaire +2 more sources
Novel non-aqueous rotavirus vaccine: Formulated for thermostability and easy administration
Human Vaccines & ImmunotherapeuticsRotavirus vaccination has greatly reduced the number of deaths caused by the virus, lowering childhood mortality by an estimated 37% globally. Although low- and middle-income countries (LMIC) demonstrate reduced efficacy than high-income countries, the ...
John W. Langston +10 more
doaj +1 more source